---
schema_version: "secwatch.filing_event.v1"
accession: "0001965040-24-000050"
form_type: "8-K"
ticker: "FTRE"
cik: "0001965040"
company_name: "Fortrea Holdings Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:10:38.316962+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Fortrea Q2 revenue down 8.6% to $662.4M, net loss $99.3M, cuts full-year guidance

## Summary
- Revenue $662.4M (-8.6% YoY); GAAP net loss $99.3M vs net income $25.0M prior year.
- Adjusted EBITDA $55.2M vs $71.9M YoY; adjusted loss per share $(0.03).
- Book-to-bill 0.96x for Q2; backlog $7.37B; trailing-12-month book-to-bill 1.16x.
- Paid down $504M debt using divestiture proceeds from Endpoint Clinical and Patient Access.
- Revised FY2024 guidance: revenue $2.70-2.75B, adjusted EBITDA $220-240M, down from prior.

## SEC filing metadata
- accession: 0001965040-24-000050
- form_type: 8-K
- ticker: FTRE
- cik: 0001965040
- company_name: Fortrea Holdings Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1965040/000196504024000050/0001965040-24-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1965040/000196504024000050/ftre-20240812.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001965040-24-000050
- JSON: https://secwatch.observer/filing/0001965040-24-000050.json
- Plain text: https://secwatch.observer/filing/0001965040-24-000050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.